Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Virtual Congress 2020

The treatment of ovarian cancer in 2020

The role of homologous recombination deficiency (HRD) and its clinical implication: Do we need it?

Date

22 Nov 2020

Session

The treatment of ovarian cancer in 2020

Topics

Tumour Site

Ovarian Cancer

Presenters

David SP Tan

Authors

D.S. Tan

Author affiliations

  • Medical Oncology, NUS-National University of Singapore-National University Health System (NUHS), 119228 - Singapore/SG

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

LIVE Q&A

Presenter: Domenica Lorusso

Session: The treatment of ovarian cancer in 2020

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.